Orkambi (lumacaftor/ivacaftor)

pCPA File Number: 21249
Negotiation Status:
Active Negotiation
Indication(s):
Cystic Fibrosis, F508del CFTR mutation
Sponsor/Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable